Sl. Castro et al., INCREASED NEOSTRIATAL TYROSINE HYDROXYLATION DURING STRESS - ROLE OF EXTRACELLULAR DOPAMINE AND EXCITATORY AMINO-ACIDS, Journal of neurochemistry, 66(2), 1996, pp. 824-833
We examined the regulation of neostriatal tyrosine hydroxylation durin
g acute stress, testing the hypothesis that excitatory amino acids (EA
As) contribute to the stress-evoked increase in dopamine (DA) synthesi
s. Dialysis probes implanted into neostriatum permitted delivery of dr
ugs and sampling of extracellular fluid, Rats were exposed to 30 min o
f intermittent tail shock during infusion of an inhibitor of aromatic
amino acid decarboxylase (AAAD), NSD-1015 (100 mu M), and DOPA was mea
sured in the dialysate. Tail shock was applied beginning either 15 min
after the onset of NSD-1015 treatment (the initial rate of DOPA accum
ulation) or 75 min after the onset of treatment (when DOPA had approac
hed steady state). Tail shock increased the steady-state levels of ext
racellular DOPA in neostriatum (+40%), However, there was no change in
the initial rate of DOPA accumulation unless animals also received th
e D-2 receptor antagonist eticlopride (50 nM), in which case an increa
se was observed (+228%). The impact of tail shock on the steady-state
level of DOPA was attenuated by the D-2 agonist quinpirole (100 mu M),
or by 2-amino-5-phosphonovalerate (APV) (100 mu M) or 6-cyano-7-nitro
quinoxaline-2,3-dione (CNQX) (100 mu M), EAA antagonists acting at NMD
A or -amino-3-hydroxy-5-methyl-4-isoxazole-4-propionate (AMPA) recepto
rs, respectively. These data suggest that acute stress normally has li
ttle effect on tyrosine hydroxylation in neostriatum due to the inhibi
tory influence of DA in the extracellular fluid. However, when that in
fluence is absent (e.g., during extended inhibition of DOPA decarboxyl
ation or blockade of DA receptors), stress increases tyrosine hydroxyl
ation via EAAs acting on NMDA and AMPA receptors. Thus, EAAs released
from corticostriatal projections may stimulate DA synthesis and thereb
y restore dopaminergic activity under conditions in which the availabi
lity of DA for release has been compromised.